Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit

Jennifer G Robinson, MD, MPH, Manju Bengularu Jayanna, MBBS, Alan S. Brown, MD, FACC, FNLA, Karen Aspry, MD, MS, FACC, FNLA, FAHA, Carl Orringer, MD, FNLA, Edward A. Gill, MD, FNLA, FASE, FACP, FACC, FAHA, Anne Goldberg, MD, FACP, FNLA, Laney K. Jones PharmD, MPH, Kevin Maki, PhD, Dave L. Dixon, PharmD, Joseph Saseen PharmD, FNLA, Daniel Soffer, MD, FNLA, FACP<

National Lipid Association Statement

View Manuscript